Explore
Trendline
MetLife Reports Strong Q3 Earnings, Analysts Maintain 'Moderate Buy' Rating
MetLife Reports Strong Q3 Earnings, Analysts Maintain 'Moderate Buy' Rating
Read More
Trendline
Acadia Realty Trust Lowers 2026 Earnings Guidance Amidst Third Quarter Loss, Affirms Dividend
Acadia Realty Trust Lowers 2026 Earnings Guidance Amidst Third Quarter Loss, Affirms Dividend
Read More
Trendline
Chevron Reports Strong Earnings Driven by Record Refining Profits, Faces Near-Term Charge
Chevron Reports Strong Earnings Driven by Record Refining Profits, Faces Near-Term Charge
Read More
Trendline
Berkshire Hathaway Shares Trade Above Fair Value, Prompting Caution Among Investors
Berkshire Hathaway Shares Trade Above Fair Value, Prompting Caution Among Investors
Read More
Trendline
Allstate Board Approves Quarterly Dividend Payable January 2027
Allstate Board Approves Quarterly Dividend Payable January 2027
Read More
Trendline
ExxonMobil Raises Dividend for 44th Consecutive Year and Plans $20 Billion in 2027 Share Buybacks
ExxonMobil Raises Dividend for 44th Consecutive Year and Plans $20 Billion in 2027 Share Buybacks
Read More
Trendline
IonQ Stock Declines 8% Amidst Broader Quantum Computing Sector Pullback
IonQ Stock Declines 8% Amidst Broader Quantum Computing Sector Pullback
Read More
Trendline
Lincoln Financial Board Declares Quarterly Cash Dividend of $0.45 Per Share
Lincoln Financial Board Declares Quarterly Cash Dividend of $0.45 Per Share
Read More
Trendline
Kraft Heinz Dividend Stability Amidst Strategic Reinvestment and Falling Free Cash Flow
Kraft Heinz Dividend Stability Amidst Strategic Reinvestment and Falling Free Cash Flow
Read More
Trendline
Sysco Corporation Board Declares Quarterly Cash Dividend of $0.55 Per Share
Sysco Corporation Board Declares Quarterly Cash Dividend of $0.55 Per Share
Read More
Trendline
Kaplan Fox Investigates Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) for Potential Securities Law Violations
Kaplan Fox Investigates Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) for Potential Securities Law Violations
Read More
Trendline
Pfizer Raises 2026 Revenue Guidance Amidst Product Transition and Dividend Scrutiny
Pfizer Raises 2026 Revenue Guidance Amidst Product Transition and Dividend Scrutiny
Read More